RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Essex Bio-Technology Stock

Essex Bio-Technology Net Income 2024

Essex Bio-Technology Net Income

0 HKD

Ticker

1061.HK

ISIN

KYG312371035

WKN

693609

In 2024, Essex Bio-Technology's profit amounted to 0 HKD, a 0% increase from the 275.26 M HKD profit recorded in the previous year.

The Essex Bio-Technology Net Income history

YEARNET INCOME (undefined HKD)
2025e-
2024e-
2023275.26
2022225.41
2021345.97
2020218.93
2019302.5
2018231.09
2017167.3
2016136.28
2015104.9
201475.27
201354.9
201239
201133.2
201026.6
200911.6
200821.8
200710.6
20064.6
200515.4
20047.6

Essex Bio-Technology Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Essex Bio-Technology, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Essex Bio-Technology from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Essex Bio-Technology’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Essex Bio-Technology. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Essex Bio-Technology’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Essex Bio-Technology’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Essex Bio-Technology’s growth potential.

Essex Bio-Technology Revenue, EBIT and net profit per share

DateEssex Bio-Technology RevenueEssex Bio-Technology EBITEssex Bio-Technology Net Income
2025e2.42 B undefined573.6 M undefined0 undefined
2024e2.25 B undefined555.88 M undefined0 undefined
20231.71 B undefined338.85 M undefined275.26 M undefined
20221.32 B undefined295.2 M undefined225.41 M undefined
20211.64 B undefined425.72 M undefined345.97 M undefined
2020978.11 M undefined229.82 M undefined218.93 M undefined
20191.28 B undefined339.75 M undefined302.5 M undefined
20181.18 B undefined261.68 M undefined231.09 M undefined
2017899.59 M undefined199.59 M undefined167.3 M undefined
2016775.66 M undefined164.7 M undefined136.28 M undefined
2015654.01 M undefined132.43 M undefined104.9 M undefined
2014518.3 M undefined99.36 M undefined75.27 M undefined
2013347 M undefined74.9 M undefined54.9 M undefined
2012267.3 M undefined50 M undefined39 M undefined
2011212.7 M undefined38.6 M undefined33.2 M undefined
2010146.3 M undefined33.2 M undefined26.6 M undefined
2009116.7 M undefined21.4 M undefined11.6 M undefined
2008214.1 M undefined30.3 M undefined21.8 M undefined
2007152.7 M undefined12.5 M undefined10.6 M undefined
200682.8 M undefined5.1 M undefined4.6 M undefined
200549.2 M undefined5 M undefined15.4 M undefined
200438.9 M undefined900,000 undefined7.6 M undefined

Essex Bio-Technology stock margins

The Essex Bio-Technology margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Essex Bio-Technology. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Essex Bio-Technology.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Essex Bio-Technology's sales revenue. A higher gross margin percentage indicates that the Essex Bio-Technology retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Essex Bio-Technology's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Essex Bio-Technology's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Essex Bio-Technology's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Essex Bio-Technology. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Essex Bio-Technology's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Essex Bio-Technology Margin History

Essex Bio-Technology Gross marginEssex Bio-Technology Profit marginEssex Bio-Technology EBIT marginEssex Bio-Technology Profit margin
2025e90.2 %23.71 %0 %
2024e90.2 %24.67 %0 %
202390.2 %19.86 %16.13 %
202290.26 %22.4 %17.11 %
202185.23 %26 %21.13 %
202081.16 %23.5 %22.38 %
201980.76 %26.55 %23.64 %
201882.75 %22.24 %19.64 %
201781.99 %22.19 %18.6 %
201680.32 %21.23 %17.57 %
201580.98 %20.25 %16.04 %
201479.35 %19.17 %14.52 %
201389.6 %21.59 %15.82 %
201291.17 %18.71 %14.59 %
201190.46 %18.15 %15.61 %
201091.8 %22.69 %18.18 %
200990.49 %18.34 %9.94 %
200847.92 %14.15 %10.18 %
200745.71 %8.19 %6.94 %
200658.82 %6.16 %5.56 %
200584.76 %10.16 %31.3 %
200488.69 %2.31 %19.54 %

Essex Bio-Technology Aktienanalyse

What does Essex Bio-Technology do?

Essex Bio-Technology Ltd is a biotechnology company that was founded in Essex, England in 1999. The company specializes in the research and development of innovative products in the healthcare sector, with a focus on the development of vaccines for globally prevalent diseases. Over the years, Essex Bio-Technology Ltd has evolved into a global company operating in Europe, Asia, Africa, and North America. It has offices in the UK, Canada, and China. The company is dedicated to improving the health and well-being of people worldwide, utilizing cutting-edge technology and scientific innovations. Its business model is based on the research, development, and marketing of biotechnology products for the pharmaceutical industry. One of the key areas of focus for Essex Bio-Technology Ltd is the discovery and development of vaccines. The company has made significant progress in particular in the development of vaccines for influenza and tuberculosis. It has also collaborated with other companies in the development of a vaccine for COVID-19. In addition to vaccines, Essex Bio-Technology Ltd has also developed products for medical diagnostics and cancer immunotherapy. These products are used in medical practice and have proven to be extremely successful. Overall, Essex Bio-Technology Ltd has developed an impressive range of products that cover important areas of healthcare. The products are of the highest quality and meet the highest standards in the biotechnology industry. In recent years, the company has established a strong partnership with the pharmaceutical industry. It has conducted collaborative research projects with some of the largest companies in the field to develop new biotechnology products. It has also played a central role in collaboration with governments and non-profit organizations worldwide to ensure that critical medical needs are met. Essex Bio-Technology Ltd stands for the highest quality standards and a commitment to improving healthcare. The company is a leader in biotechnological research and development and has made a name for itself in the pharmaceutical industry. It is a company to be proud of and one that is at the forefront of the journey towards better healthcare for all worldwide. Essex Bio-Technology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Essex Bio-Technology's Profit Margins

The profit margins of Essex Bio-Technology represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Essex Bio-Technology's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Essex Bio-Technology's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Essex Bio-Technology's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Essex Bio-Technology’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Essex Bio-Technology stock

How much profit has Essex Bio-Technology made this year?

Essex Bio-Technology has made 0 HKD this year.

How has the profit developed compared to last year?

The profit has increased by 0% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Essex Bio-Technology publish its earnings?

Essex Bio-Technology publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Essex Bio-Technology?

The profits of Essex Bio-Technology are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Essex Bio-Technology?

You can learn more about the earnings of Essex Bio-Technology by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Essex Bio-Technology pay?

Over the past 12 months, Essex Bio-Technology paid a dividend of 0.07 HKD . This corresponds to a dividend yield of about 2.86 %. For the coming 12 months, Essex Bio-Technology is expected to pay a dividend of 0.08 HKD.

What is the dividend yield of Essex Bio-Technology?

The current dividend yield of Essex Bio-Technology is 2.86 %.

When does Essex Bio-Technology pay dividends?

Essex Bio-Technology pays a quarterly dividend. This is distributed in the months of July, September, June, October.

How secure is the dividend of Essex Bio-Technology?

Essex Bio-Technology paid dividends every year for the past 0 years.

What is the dividend of Essex Bio-Technology?

For the upcoming 12 months, dividends amounting to 0.08 HKD are expected. This corresponds to a dividend yield of 3.15 %.

In which sector is Essex Bio-Technology located?

Essex Bio-Technology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Essex Bio-Technology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Essex Bio-Technology from 9/24/2024 amounting to 0.06 HKD, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.

When did Essex Bio-Technology pay the last dividend?

The last dividend was paid out on 9/24/2024.

What was the dividend of Essex Bio-Technology in the year 2023?

In the year 2023, Essex Bio-Technology distributed 0.095 HKD as dividends.

In which currency does Essex Bio-Technology pay out the dividend?

The dividends of Essex Bio-Technology are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Essex Bio-Technology

Our stock analysis for Essex Bio-Technology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Essex Bio-Technology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.